PE20090953A1 - Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de bace - Google Patents
Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de baceInfo
- Publication number
- PE20090953A1 PE20090953A1 PE2008001440A PE2008001440A PE20090953A1 PE 20090953 A1 PE20090953 A1 PE 20090953A1 PE 2008001440 A PE2008001440 A PE 2008001440A PE 2008001440 A PE2008001440 A PE 2008001440A PE 20090953 A1 PE20090953 A1 PE 20090953A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- amino
- benzyl
- halo
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
REFRIDA A UN DERIVADO SULFONA DE FORMULA (I), DONDE R1 ES H, HALOGENO, ALQUILO C1-C8; R2 ES H, HALOGENO, ALQUILO C1-C8, HALO-ALQUILO C1-C8, ENTRE OTROS; R3 ES H, HALO-ALQUILO C1-C8, HIDROXI-ALQUILO C1-C8, ENTRE OTROS; R4 ES H, ALQUILO C1-C8, FORMILO, ENTRE OTROS; R5 ES H, HALOGENO, ALQUILO C1-C8, ALQUENILO C2-C8, ENTRE OTROS; R6 ES OXO O ESTA AUSENTE; R7 ESTA AUSENTE O ES OXO, IMINO, BENCIL-IMINO, FORMIL-IMINO, ENTRE OTROS; R8 ES H, ALQUILO C1-C8, HIDROXI-ALQUILO C1-C8, HALO-ALQUILO C1-C8, ENTRE OTROS; R9 ES H, ALQUILO C1-C8, HALO-ALQUILO C1-C8, ENTRE OTROS; R10 ES UN GRUPO ARILO O HETEROARILO OPCIONALMENTE SUSTITUIDO CON HALOGENO, OH, ALQUILO C1-C8, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: CLORHIDRATO DE (3S*,4S*,5R*)-3-(4-AMINO-3-FLUORO-BENCIL)-5-(3-TERBUTIL-BENCIL-AMINO)-1,1-DIOXO-HEXAHIDRO-1LAMBDA*6*-TIOPIRAN-4-OL, (3S,4S,5R)-3-(4-AMINO-3-BROMO-5-FLUORO-BENCIL)-5-[3-(1,1-DIFLUORO-ETIL)-BENCIL-AMINO]-1,1-DIOXO-HEXAHIDRO-1LAMBDA*6*-TIOPIRAN-4-OL, (3S,4S,5R)-3-(4-AMINO-3-BROMO-5-FLUORO-BENCIL)-5-[3-(2,2-DIMETIL-PROPIL)-BENCIL-AMINO]-1,1-DIOXO-HEXAHIDRO-1LAMBDA*6*-TIOPIRAN-4-OL, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE BACE Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS, TRANSTORNOS NEUROLOGICOS, ENTRE OTRAS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07114881 | 2007-08-23 | ||
EP08160123 | 2008-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090953A1 true PE20090953A1 (es) | 2009-08-10 |
Family
ID=39789883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001440A PE20090953A1 (es) | 2007-08-23 | 2008-08-25 | Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de bace |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090054427A1 (es) |
EP (1) | EP2190833A1 (es) |
JP (1) | JP2010536831A (es) |
KR (1) | KR20100061805A (es) |
CN (1) | CN101835771A (es) |
AR (1) | AR068062A1 (es) |
AU (1) | AU2008290561A1 (es) |
BR (1) | BRPI0815673A2 (es) |
CA (1) | CA2697254A1 (es) |
CL (1) | CL2008002480A1 (es) |
EA (1) | EA201000340A1 (es) |
MX (1) | MX2010002007A (es) |
PE (1) | PE20090953A1 (es) |
TW (1) | TW200916097A (es) |
WO (1) | WO2009024615A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011000390A (es) * | 2008-07-10 | 2011-03-01 | Novartis Ag | Sulfonas ciclicas con sustitucion de amino-bencilo utiles coimo inhibidores de bace. |
US9066948B2 (en) | 2010-07-16 | 2015-06-30 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines |
US9242943B2 (en) * | 2011-01-18 | 2016-01-26 | Siena Biotech S.P.A. | 1,4 oxazines as BACE1 and/or BACE2 inhibitors |
WO2013109632A2 (en) | 2012-01-16 | 2013-07-25 | The Rockefeller University | Organic compounds |
CA2899938C (en) | 2013-02-12 | 2021-10-19 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
CN106674264A (zh) * | 2016-12-20 | 2017-05-17 | 苏州汉德创宏生化科技有限公司 | (2,2,2‑三氟乙氧基)苯硼酸类化合物的合成方法 |
WO2019246085A1 (en) * | 2018-06-19 | 2019-12-26 | Celecor Therapeutics, Inc. | Deuterated ruc-4 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA001534B1 (ru) * | 1996-02-07 | 2001-04-23 | Варнер-Ламберт Компани | Производные циклической аминокислоты или их фармацевтически приемлемые соли, фармацевтическая композиция и способ лечения депрессии, состояний паники, страха и болевых ощущений |
PL341231A1 (en) * | 1997-12-16 | 2001-03-26 | Warner Lambert Co | 4(3)-substitute derivatives of 4(3)aminomethyl(thio)pyrane or piperidine derivatives (analogues of garbapentin), their production and application in treating neurological disorders |
GB0602951D0 (en) * | 2006-02-14 | 2006-03-29 | Novartis Ag | Organic Compounds |
-
2008
- 2008-08-22 AU AU2008290561A patent/AU2008290561A1/en not_active Abandoned
- 2008-08-22 EP EP08787429A patent/EP2190833A1/en not_active Withdrawn
- 2008-08-22 BR BRPI0815673-5A2A patent/BRPI0815673A2/pt not_active Application Discontinuation
- 2008-08-22 CA CA2697254A patent/CA2697254A1/en not_active Abandoned
- 2008-08-22 MX MX2010002007A patent/MX2010002007A/es not_active Application Discontinuation
- 2008-08-22 US US12/196,461 patent/US20090054427A1/en not_active Abandoned
- 2008-08-22 KR KR1020107006213A patent/KR20100061805A/ko not_active Application Discontinuation
- 2008-08-22 JP JP2010521442A patent/JP2010536831A/ja active Pending
- 2008-08-22 CL CL2008002480A patent/CL2008002480A1/es unknown
- 2008-08-22 WO PCT/EP2008/061030 patent/WO2009024615A1/en active Application Filing
- 2008-08-22 CN CN200880112386A patent/CN101835771A/zh active Pending
- 2008-08-22 EA EA201000340A patent/EA201000340A1/ru unknown
- 2008-08-25 AR ARP080103691A patent/AR068062A1/es unknown
- 2008-08-25 TW TW097132452A patent/TW200916097A/zh unknown
- 2008-08-25 PE PE2008001440A patent/PE20090953A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20100061805A (ko) | 2010-06-09 |
EA201000340A1 (ru) | 2010-08-30 |
JP2010536831A (ja) | 2010-12-02 |
MX2010002007A (es) | 2010-03-10 |
US20090054427A1 (en) | 2009-02-26 |
TW200916097A (en) | 2009-04-16 |
CA2697254A1 (en) | 2009-02-26 |
CL2008002480A1 (es) | 2009-05-15 |
AR068062A1 (es) | 2009-11-04 |
BRPI0815673A2 (pt) | 2015-02-18 |
EP2190833A1 (en) | 2010-06-02 |
AU2008290561A1 (en) | 2009-02-26 |
CN101835771A (zh) | 2010-09-15 |
WO2009024615A1 (en) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090953A1 (es) | Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de bace | |
PE20061106A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
PE20171342A1 (es) | Compuestos y su uso como inhibidores de bace | |
PE20091095A1 (es) | Moduladores de gamma secretasa | |
PE20091977A1 (es) | Compuestos de quinuclidina como ligandos del receptor nicotinico de acetilcolina alfa-7 | |
PE20110875A1 (es) | Derivados de isoindol como inhibidores de bace | |
AR071609A1 (es) | Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1 | |
PE20081441A1 (es) | Subtipo de amidas selectivas de diazabicicloalcanos | |
PE20161400A1 (es) | Derivados de isoindolin-1-ona con actividad positiva del modulador alosterico del receptor colinergico muscarinico m1 para el tratamiento de la enfermedad de alzheimer | |
AR065811A1 (es) | Derivados de 2-amino-4h-imidazol-4-ona,composiciones farmaceuticas que los contienen y usos para el tratamiento de la enfermedad de alzheimer y otros trastornos neurodegenerativos. | |
PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
ECSP099461A (es) | Compuesto heteromonocíclico y uso del mismo | |
PE20091811A1 (es) | DERIVADOS DE IMIDAZOLIDINONA COMO INHIBIDORES DE 11b-HSD1 | |
PE20080895A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
AR074306A1 (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes | |
AR070517A1 (es) | Piperidinas inhibidoras de 11 beta-hidroxiesteroide deshidrogenasa 1 | |
AR067673A1 (es) | Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas. | |
PE20120693A1 (es) | Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2) | |
PE20091008A1 (es) | Derivados heterociclicos como moduladores de fosfoinositida 3-cinasa | |
PE20090648A1 (es) | Compuestos para el tratamiento de la hepatitis c | |
PE20071116A1 (es) | Compuestos de heteroarilo biciclicos como inhibidores de pde10 | |
PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
PE20091694A1 (es) | DERIVADOS POLISUSTITUIDOS DE 6-HETEROARIL-IMIDAZO[1,2-a] PIRIDINAS COMO MODULADORES DE LOS RECEPTORES NOT Y SU PREPARACION | |
UY29316A1 (es) | Miméticos de glucocorticoides, métodos para prepararlos, composiciones farmacéuticas, y usos de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |